Literature DB >> 22986709

Polymorphic transporters and platinum pharmacodynamics.

Jason A Sprowl1, Rachel A Ness, Alex Sparreboom.   

Abstract

Several solute carriers and ATP-binding cassette transporters have been implicated in the influx or efflux of platinum-based chemotherapeutic agents such as cisplatin, carboplatin, and oxaliplatin. Given that many of these proteins are highly polymorphic, the genetic status of these proteins could be an important contributor to the extensive interindividual pharmacokinetic variability associated with the clinical use of these agents. In this review article, we provide an updated overview of the various transporters that have shown promise in animal models or patient populations in facilitating the movement of platinum-based agents across cell membranes, and how their function is associated with drug disposition or pharmacodynamic effects.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22986709      PMCID: PMC3705946          DOI: 10.2133/dmpk.dmpk-12-rv-073

Source DB:  PubMed          Journal:  Drug Metab Pharmacokinet        ISSN: 1347-4367            Impact factor:   3.614


  123 in total

1.  Tissue distribution and renal developmental changes in rat organic cation transporter mRNA levels.

Authors:  A L Slitt; N J Cherrington; D P Hartley; T M Leazer; C D Klaassen
Journal:  Drug Metab Dispos       Date:  2002-02       Impact factor: 3.922

2.  The effects of genetic polymorphisms in the organic cation transporters OCT1, OCT2, and OCT3 on the renal clearance of metformin.

Authors:  M V Tzvetkov; S V Vormfelde; D Balen; I Meineke; T Schmidt; D Sehrt; I Sabolić; H Koepsell; J Brockmöller
Journal:  Clin Pharmacol Ther       Date:  2009-06-17       Impact factor: 6.875

Review 3.  First-line chemotherapy of disseminated germ cell tumors.

Authors:  Craig Nichols; Christian Kollmannsberger
Journal:  Hematol Oncol Clin North Am       Date:  2011-06       Impact factor: 3.722

4.  Identification and functional characterization of a new human kidney-specific H+/organic cation antiporter, kidney-specific multidrug and toxin extrusion 2.

Authors:  Satohiro Masuda; Tomohiro Terada; Atsushi Yonezawa; Yuko Tanihara; Koshiro Kishimoto; Toshiya Katsura; Osamu Ogawa; Ken-ichi Inui
Journal:  J Am Soc Nephrol       Date:  2006-06-28       Impact factor: 10.121

5.  Gene expression levels and immunolocalization of organic ion transporters in the human kidney.

Authors:  Hideyuki Motohashi; Yuji Sakurai; Hideyuki Saito; Satohiro Masuda; Yumiko Urakami; Maki Goto; Atsushi Fukatsu; Osamu Ogawa; Ken-Ichi Inui
Journal:  J Am Soc Nephrol       Date:  2002-04       Impact factor: 10.121

6.  Regulation of renal organic anion and cation transporters by thymoquinone in cisplatin induced kidney injury.

Authors:  Ramazan Ulu; Ayhan Dogukan; Mehmet Tuzcu; Hasan Gencoglu; Mustafa Ulas; Necip Ilhan; Irfana Muqbil; Ramzi M Mohammad; Omer Kucuk; Kazim Sahin
Journal:  Food Chem Toxicol       Date:  2012-03-03       Impact factor: 6.023

7.  Cloning and characterization of two human polyspecific organic cation transporters.

Authors:  V Gorboulev; J C Ulzheimer; A Akhoundova; I Ulzheimer-Teuber; U Karbach; S Quester; C Baumann; F Lang; A E Busch; H Koepsell
Journal:  DNA Cell Biol       Date:  1997-07       Impact factor: 3.311

8.  MRP2 and GSTP1 polymorphisms and chemotherapy response in advanced non-small cell lung cancer.

Authors:  Ning Sun; Xinchen Sun; Baoan Chen; Hongyan Cheng; Jifeng Feng; Lu Cheng; Zuhong Lu
Journal:  Cancer Chemother Pharmacol       Date:  2009-07-01       Impact factor: 3.333

9.  Interaction of Cisplatin with the human organic cation transporter 2.

Authors:  Kelly K Filipski; Walter J Loos; Jaap Verweij; Alex Sparreboom
Journal:  Clin Cancer Res       Date:  2008-06-15       Impact factor: 12.531

Review 10.  Theanine and glutamate transporter inhibitors enhance the antitumor efficacy of chemotherapeutic agents.

Authors:  Tomomi Sugiyama; Yasuyuki Sadzuka
Journal:  Biochim Biophys Acta       Date:  2003-12-05
View more
  16 in total

1.  Mitigation of acute kidney injury by cell-cycle inhibitors that suppress both CDK4/6 and OCT2 functions.

Authors:  Navjotsingh Pabla; Alice A Gibson; Mike Buege; Su Sien Ong; Lie Li; Shuiying Hu; Guoqing Du; Jason A Sprowl; Aksana Vasilyeva; Laura J Janke; Eberhard Schlatter; Taosheng Chen; Giuliano Ciarimboli; Alex Sparreboom
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-06       Impact factor: 11.205

Review 2.  A review of the literature on the relationships between genetic polymorphisms and chemotherapy-induced nausea and vomiting.

Authors:  Komal P Singh; Anand A Dhruva; Elena Flowers; Kord M Kober; Christine Miaskowski
Journal:  Crit Rev Oncol Hematol       Date:  2017-11-20       Impact factor: 6.312

3.  Genetic variation in platinating agent and taxane pathway genes as predictors of outcome and toxicity in advanced non-small-cell lung cancer.

Authors:  Jatinder Kaur Lamba; Brooke L Fridley; Taraswi M Ghosh; Qing Yu; Gaurav Mehta; Pankaj Gupta
Journal:  Pharmacogenomics       Date:  2014       Impact factor: 2.533

Review 4.  Recent Developments of Novel Pharmacologic Therapeutics for Prevention of Chemotherapy-Induced Peripheral Neuropathy.

Authors:  Shuiying Hu; Kevin M Huang; Elizabeth J Adams; Charles L Loprinzi; Maryam B Lustberg
Journal:  Clin Cancer Res       Date:  2019-05-23       Impact factor: 12.531

5.  Effect of transporter and DNA repair gene polymorphisms to lung cancer chemotherapy toxicity.

Authors:  Juan Chen; Lin Wu; Ying Wang; Jiye Yin; Xiangping Li; Zhan Wang; Huihua Li; Ting Zou; Chenyue Qian; Chuntian Li; Wei Zhang; Honghao Zhou; Zhaoqian Liu
Journal:  Tumour Biol       Date:  2015-09-11

6.  Auraptene Attenuates Malignant Properties of Esophageal Stem-Like Cancer Cells.

Authors:  Saffiyeh Saboor-Maleki; Fatemeh B Rassouli; Maryam M Matin; Mehrdad Iranshahi
Journal:  Technol Cancer Res Treat       Date:  2016-05-20

7.  Neuronal uptake transporters contribute to oxaliplatin neurotoxicity in mice.

Authors:  Kevin M Huang; Alix F Leblanc; Muhammad Erfan Uddin; Ji Young Kim; Mingqing Chen; Eric D Eisenmann; Alice A Gibson; Yang Li; Kristen W Hong; Duncan DiGiacomo; Sherry H Xia; Paola Alberti; Alessia Chiorazzi; Stephen N Housley; Timothy C Cope; Jason A Sprowl; Jing Wang; Charles L Loprinzi; Anne Noonan; Maryam B Lustberg; Guido Cavaletti; Navjot Pabla; Shuiying Hu; Alex Sparreboom
Journal:  J Clin Invest       Date:  2020-09-01       Impact factor: 14.808

8.  The identification of dual protective agents against cisplatin-induced oto- and nephrotoxicity using the zebrafish model.

Authors:  Jaime N Wertman; Nicole Melong; Matthew R Stoyek; Olivia Piccolo; Stewart Langley; Benno Orr; Shelby L Steele; Babak Razaghi; Jason N Berman
Journal:  Elife       Date:  2020-07-28       Impact factor: 8.140

9.  Solute Carrier Transportome in Chemotherapy-Induced Adverse Drug Reactions.

Authors:  Jason T Anderson; Kevin M Huang; Maryam B Lustberg; Alex Sparreboom; Shuiying Hu
Journal:  Rev Physiol Biochem Pharmacol       Date:  2022       Impact factor: 7.500

Review 10.  Facilitating the Cellular Accumulation of Pt-Based Chemotherapeutic Drugs.

Authors:  Ian Henry Lambert; Belinda Halling Sørensen
Journal:  Int J Mol Sci       Date:  2018-08-01       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.